Press Releases

Varian Showcasing Latest Proton Therapy Systems and Technology at PTCOG Conference 58

Varian (NYSE: VAR) announced it will be showcasing its new ProBeam® 360° proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy...

Varian to Showcase Software Solutions at ASCO Annual Meeting

Varian (NYSE: VAR) today announced it will be showcasing its Noona® patient management system and its 360 Oncology™ care management platform, May 31-June 4 in Chicago, Illinois at the 2019 ASCO...

Varian Eclipse User Takes Top Spot in 2019 TROG Pancreas Treatment Plan Study

Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic Body Radiation Therapy (SBRT)...

Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International

Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (NYSE: VAR) today announced it has entered...

Varian Announces Incremental Gross Impact of New Tariffs

Varian (NYSE: VAR) today announced preliminary estimates of the incremental gross impact of new tariffs. Over the past week, the US increased tariffs on certain goods (US List 3), and imposed new...

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact...

Papua New Guinea Hospital Selects Varian Cancer Care Solution

Varian (NYSE: VAR) today announced it was selected by Port Moresby General Hospital (PMGH) in Papua New Guinea to equip its cancer treatment center with the Halcyon™ radiotherapy system, as well...

Varian Acquires CyberHeart

Acquisition Key Highlights The CyberHeart acquisition secures significant intellectual property/patents that cover the use of radiation in the heart. Early positive clinical evidence suggests that...

Varian Selected to Equip Two Proton Therapy Centers in Norway

Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy centers in Norway with the ProBeam®...

Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China

Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical application and research. The...